AR059136A1 - Derivados de indol-3-il-carbonil-espiro-piperidina - Google Patents
Derivados de indol-3-il-carbonil-espiro-piperidinaInfo
- Publication number
- AR059136A1 AR059136A1 ARP070100032A ARP070100032A AR059136A1 AR 059136 A1 AR059136 A1 AR 059136A1 AR P070100032 A ARP070100032 A AR P070100032A AR P070100032 A ARP070100032 A AR P070100032A AR 059136 A1 AR059136 A1 AR 059136A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- halogen
- nririi
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicacion 1: Compuestos de la formula general (1) en la A se elige los siguientes grupos (a), (b), (c), (d), (e) y (f): X puede ser igual o diferente y es CRiiiRiv, NRiii u O, en las que en (a), solamente una X puede ser O, la otra es CRiiiEiv o NRiii; R1 es H, alquilo C1-6 opcionalmente sustituido por CN, o es arilo, heteroarilo de 5 o 6 eslabones o sulfonilarilo, que están opcionalmente sustituidos por uno o más B, o es -(CH2)m-Ra, en el que Ra es: R3 es H, o es halogeno, o es -(CO)-Rc, en el que Rc es: alquilo C1-6, -(CH2)n-NRiRii, -(CH2)n-NRiiiRiv, heterocicloalquilo de 5 o 6 eslabones opcionalmente sustituido por alquilo C1-6, o es alquilo C1-6 o arilo, que están opcionalmente sustituidos por halogeno, -O(CO)-alquilo C1-6, o por -NH(CO)Rd, en el que Rd es alquilo C1-6 opcionalmente sustituido por halogeno o nitro o Rd es arilo o un heteroarilo de 5 o 6 eslabones, que están opcionalmente sustituidos por halogeno, nitro, alquilo C1-6 o haloalquilo C1-6; R4 es uno o más de H, halogeno, alquilo C1-6 o alcoxi C1-6, CN o dos R4 pueden formar un puente oxo o dioxo junto con el anillo fenilo al que están unidos, B es halogeno, CN, NRiRii, alquilo C1-6 opcionalmente sustituido por CN, halogeno o alcoxi C1-6, alcoxi C1-6, haloalcoxi C1-6, cicloalquilo C3-6, -C(O)O-alquilo C1-6, -C(O)-NRiRii, -C(O)-alquilo C1-6, -S(O)2-alquilo C1-6, -S(O)2-NRiRii, (CRiiiRiv)n-fenilo o (CRiiiRIV)n-heteroarilo de 5 o 6 eslabones, dichos restos fenilo o heteroarilo de 5 o 6 eslabones están opcionalmente sustituidos por uno o más sustituyentes elegidos entre el grupo formado por: halogeno, CN, NRiRii, alquilo C1-6 opcionalmente sustituido por CN o alcoxi C1-6, alcoxi C1-6, haloalcoxi C1-6, cicloalquilo C3-6, -C(O)O-alquilo C1-6, - C(O)-NRiRii, -C(O)-alquilo C1-6, -S(O)2-alquilo C1-6, -S(O)2-NRiRii; Ri y Rii son H, alquilo C1-6, alquileno C1-6-NRiiiRiv, -(CO)O-alquilo C1-6, -C(O)-NRiiiRiv, -C(O)-alquilo C1-6, -S(O)2-alquilo C1-6 o -S(O)2-NRiiiRiv; Riii es H, alquilo C1-6 o alquileno C1-6-N(Riv)2; Riv es H o alquilo C1-6; m es un numero de 1 a 6; n es un numero de 0 a 4, así como las sales farmacéuticamente aceptables de los mismos. La invencion se refiere además a composiciones farmacéuticas que contienen dichos compuestos, a su utilizacion en medicamentos contra dismenorrea, hipertension, fallo cardíaco cronico, secrecion inapropiada de vasopresina, cirrosis hepática, síndrome nefrotico, trastorno obsesivo-compulsivo, ansiedad y trastornos depresivos y a métodos para la obtencion de dichos compuestos
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06100118 | 2006-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059136A1 true AR059136A1 (es) | 2008-03-12 |
Family
ID=37989141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100032A AR059136A1 (es) | 2006-01-05 | 2007-01-04 | Derivados de indol-3-il-carbonil-espiro-piperidina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7351706B2 (es) |
| EP (1) | EP1973913A1 (es) |
| JP (1) | JP2009522318A (es) |
| KR (1) | KR101121349B1 (es) |
| CN (1) | CN101356174B (es) |
| AR (1) | AR059136A1 (es) |
| AU (1) | AU2006334423B2 (es) |
| BR (1) | BRPI0620951A2 (es) |
| CA (1) | CA2634120A1 (es) |
| IL (1) | IL192401A0 (es) |
| NO (1) | NO20082733L (es) |
| RU (1) | RU2420529C2 (es) |
| TW (1) | TW200734343A (es) |
| WO (1) | WO2007077122A1 (es) |
| ZA (1) | ZA200805574B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
| EP2374455A3 (en) * | 2004-08-19 | 2012-03-28 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| US7786141B2 (en) * | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| US7863449B2 (en) * | 2004-11-29 | 2011-01-04 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CN101273046B (zh) * | 2005-09-28 | 2011-05-25 | 弗·哈夫曼-拉罗切有限公司 | 作为加压素受体拮抗剂的吲哚-3-基-羰基氮杂螺环衍生物 |
| AU2006330866A1 (en) * | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| AU2007221214A1 (en) * | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| JP2010500412A (ja) * | 2006-08-15 | 2010-01-07 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
| WO2008021545A2 (en) * | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2670671A1 (en) * | 2006-12-07 | 2008-06-12 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
| WO2009045519A1 (en) * | 2007-10-03 | 2009-04-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| US8846684B2 (en) | 2011-03-31 | 2014-09-30 | The Regents Of The University Of Michigan | Arbovirus inhibitors and uses thereof |
| EA026431B1 (ru) | 2012-03-16 | 2017-04-28 | Вайтаи Фармасьютиклз, Инк. | Модуляторы x рецепторов печени |
| JP6114814B2 (ja) | 2012-03-16 | 2017-04-12 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | 肝臓ｘレセプターモジュレーター |
| JP6530407B2 (ja) | 2013-12-19 | 2019-06-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | スピロ−オキサゾロン |
| ES2951874T3 (es) * | 2017-09-05 | 2023-10-25 | Neumora Therapeutics Inc | Antagonistas del receptor de vasopresina y productos y métodos relacionados con los mismos |
| TW202024083A (zh) | 2018-09-03 | 2020-07-01 | 德商拜耳廠股份有限公司 | 3,9-二氮雜螺[5.5]十一烷化合物 |
| WO2020048830A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048831A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4349549A (en) * | 1981-05-18 | 1982-09-14 | Syntex (U.S.A.) Inc. | Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s |
| WO1999009984A1 (en) | 1997-08-28 | 1999-03-04 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
| US6013652A (en) * | 1997-12-04 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin antagonists |
| WO2001022919A2 (en) | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| GB0003397D0 (en) * | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
| CA2499329C (en) * | 2002-10-03 | 2009-04-21 | F. Hoffmann-La Roche Ag | Indole-3-carboxamides as glucokinase (gk) activators |
| DK1904477T3 (da) | 2005-07-14 | 2009-03-16 | Hoffmann La Roche | Indol-3-carbonyl-spiro-piperodom-derivater som V1A-receptorantagonister |
-
2006
- 2006-12-18 US US11/640,739 patent/US7351706B2/en not_active Expired - Fee Related
- 2006-12-19 CN CN2006800504473A patent/CN101356174B/zh not_active Expired - Fee Related
- 2006-12-19 KR KR1020087016220A patent/KR101121349B1/ko not_active IP Right Cessation
- 2006-12-19 BR BRPI0620951-3A patent/BRPI0620951A2/pt not_active IP Right Cessation
- 2006-12-19 CA CA002634120A patent/CA2634120A1/en not_active Abandoned
- 2006-12-19 WO PCT/EP2006/069897 patent/WO2007077122A1/en active Application Filing
- 2006-12-19 RU RU2008125813/04A patent/RU2420529C2/ru not_active IP Right Cessation
- 2006-12-19 AU AU2006334423A patent/AU2006334423B2/en not_active Ceased
- 2006-12-19 JP JP2008548964A patent/JP2009522318A/ja not_active Ceased
- 2006-12-19 EP EP06841445A patent/EP1973913A1/en not_active Withdrawn
-
2007
- 2007-01-02 TW TW096100068A patent/TW200734343A/zh unknown
- 2007-01-04 AR ARP070100032A patent/AR059136A1/es not_active Application Discontinuation
-
2008
- 2008-06-18 NO NO20082733A patent/NO20082733L/no not_active Application Discontinuation
- 2008-06-23 IL IL192401A patent/IL192401A0/en unknown
- 2008-06-25 ZA ZA200805574A patent/ZA200805574B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2008125813A (ru) | 2010-02-10 |
| KR101121349B1 (ko) | 2012-03-09 |
| JP2009522318A (ja) | 2009-06-11 |
| CN101356174B (zh) | 2011-11-23 |
| AU2006334423B2 (en) | 2011-09-22 |
| IL192401A0 (en) | 2008-12-29 |
| CN101356174A (zh) | 2009-01-28 |
| KR20080073364A (ko) | 2008-08-08 |
| BRPI0620951A2 (pt) | 2011-11-29 |
| CA2634120A1 (en) | 2007-07-12 |
| WO2007077122A1 (en) | 2007-07-12 |
| NO20082733L (no) | 2008-10-02 |
| US20070155761A1 (en) | 2007-07-05 |
| AU2006334423A1 (en) | 2007-07-12 |
| RU2420529C2 (ru) | 2011-06-10 |
| TW200734343A (en) | 2007-09-16 |
| ZA200805574B (en) | 2009-12-30 |
| EP1973913A1 (en) | 2008-10-01 |
| US7351706B2 (en) | 2008-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR059136A1 (es) | Derivados de indol-3-il-carbonil-espiro-piperidina | |
| AR057086A1 (es) | Derivados de indol-3- il-carbonil-piperidina y piperazina, composicion farmaceutica y proceso de preparacion del compuesto | |
| ES2552320T3 (es) | Nuevas piridín-2-onas y piridazín-3-onas sustituidas | |
| AR047056A1 (es) | Derivados de pirimidinas condensadas. composiciones farmacéuticas | |
| AR054830A1 (es) | Derivados de indol -3-il-espiro-piperidina como antagonista del receptor v1a | |
| AR047456A1 (es) | Derivados de amidas, procesos para su preparacion y uso como insecticidas | |
| AR041672A1 (es) | Compuesto biciclico de benzamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimiento para prepararlo | |
| AR048055A1 (es) | Derivados de pirimidina como inhibidores de dipeptidil peptidasa | |
| AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
| AR047903A1 (es) | Compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c | |
| AR051092A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa | |
| CO6160296A2 (es) | Derivados de acido benzoazepin-oxi-acetico como agonistas de receptores activados por proliferador de peroxisona delta usados para incrementar la lipoproteina de alta densidad-colesterol-colesterol reducir la lipoproteina de baja densidad-colesterol | |
| AR060173A1 (es) | Derivados de piridina y de pirimidina como antagonistas del mglur2, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de trastornos del snc. | |
| AR052568A1 (es) | Derivados de pirazolo -pirimidina como antagonstas de mglur2 | |
| AR047976A1 (es) | Compuestos inmunosupresores y composiciones | |
| AR048413A1 (es) | Compuestos prolina 3,4- (ciclopentil) - fusionados , como inhibidores de serina proteasa ns3 del virus de la hepatitis c | |
| RS51471B (en) | BIPHYNYLOXYXIC ACID DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASES | |
| CO5700754A2 (es) | Derivados de piperazina y su uso en el tratamiento de enfermedades neurologicas y psiquiatricas | |
| AR066669A1 (es) | Derivados de imidazolona como inhibidores de bencimidazolona quimasa. composiciones farmaceuticas. | |
| AR056188A1 (es) | Derivados indol-3-il-carbonil-piperidin-benzoimidazol como antagonistas del receptor v1a | |
| AR059094A1 (es) | Derivados de ciclohexil - sulfonamida | |
| AR041298A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| AR082696A1 (es) | Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras | |
| CO5640135A2 (es) | Derivados de 4-(4-(heterociclilalcoxi)-1-(heterociclil-carbonil)piperidina y compuestos relacionados como antagonistas de histamina h3 para el tratamiento de enfermedades neurologicas tales como alzheimer | |
| AR068376A1 (es) | Amidas heterociclicas utiles para inhibir la via hedgehog. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |